Li Nan

1.7k citations

44 papers · 1.1k indexed · h-index 19

Impact in

Oncology top 10%
- CAR-T cell therapy research
- Cancer-related Molecular Pathways
Genetics top 10%
- Virus-based gene therapy research

Papers in ⓘ

Molecular Biology 18
- RNA modifications and cancer 3
Oncology 16
- Bone health and treatments 4
- Cancer-related Molecular Pathways 3

Co-authors: Sudhir Agrawal (3 shared papers)Gary A. Piazza (7 shared papers)Adam B. Keeton (7 shared papers)Ruiwen Zhang (4 shared papers)Dong Soo Yu (2 shared papers)Bernard D. Gary (6 shared papers)Elizabeth A. Beierle (8 shared papers)Huamiao Wang (1 shared paper)
Journals: Neuro-Oncology (2 papers)Cancer Research (2 papers)Cancer Prevention Research (2 papers)Pediatric Research (2 papers)Blood (2 papers)
Partner nations: United States China Egypt

In The Last Decade

Li Nan

43 papers receiving 1.1k citations

Peers

Countries citing papers authored by Li Nan

Since Specialization

Citations

This map shows the geographic impact of Li Nan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Nan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Nan more than expected).

Fields of papers citing papers by Li Nan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Nan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Nan. The network helps show where Li Nan may publish in the future.

Co-authors

The 25 scholars most cited alongside Li Nan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Li Nan Line = papers co-authored together Li Nan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Changes in Intestinal Morphology and Permeability in the BioBreeding Rat Before the Onset of Type 1 Diabetes Journal of Pediatric Gastroenterology and Nutrition ·Josef Neu, Christopher M Reverte, Amy D. Mackey, Kellym Liboni, Lauren M Tuhacek‐Tenace, Marguerite Hatch, Li Nan, Ricardo A. Caicedo, Desmond Schatz, Mark A. Atkinson	2005	122
2	Antisense anti-MDM2 oligonucleotides as a novel therapeutic approach to human breast cancer: in vitro and in vivo activities and mechanisms. PubMed ·Huamiao Wang, Li Nan, Dong Soo Yu, Sudhir Agrawal, Ruiwen Zhang	2001	91
3	EX VIVO EXPANDED HUMAN Vλ9Vδ2+ λδ-T CELLS MEDIATE INNATE ANTITUMOR ACTIVITY AGAINST HUMAN PROSTATE CANCER CELLS IN VITRO The Journal of Urology ·Zhiyong Liu, Ben Guo, Bradley Gehrs, Li Nan, Richard D. Lopez	2005	81
4	Colon Tumor Cell Growth–Inhibitory Activity of Sulindac Sulfide and Other Nonsteroidal Anti-Inflammatory Drugs Is Associated with Phosphodiesterase 5 Inhibition Cancer Prevention Research ·Heather N. Tinsley, Bernard D. Gary, Jose Thaiparambil, Li Nan, Wenyan Lü, Yonghe Li, Yulia Maxuitenko, Adam B. Keeton, Gary A. Piazza	2010	76
5	A Novel Sulindac Derivative that Potently Suppresses Colon Tumor Cell Growth by Inhibiting cGMP Phosphodiesterase and β-Catenin Transcriptional Activity Cancer Prevention Research ·Jason Whitt, Li Nan, Heather N. Tinsley, Xi Chen, Wei Zhang, Yonghe Li, Bernard D. Gary, Adam B. Keeton, Yaguang Xi, Alireza Abadi, William E. Grizzle, Gary A. Piazza	2012	65
6	Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression Scientific Reports ·Gregory K. Friedman, Joshua D. Bernstock, Dongquan Chen, Li Nan, Blake P. Moore, Virginia Kelly, Samantha Youngblood, Catherine P. Langford, Xiaosi Han, Eric Ring, Elizabeth A. Beierle, G. Yancey Gillespie, James M. Markert	2018	59
7	Heparanase Enhances Local and Systemic Osteolysis in Multiple Myeloma by Upregulating the Expression and Secretion of RANKL Cancer Research ·Yang Yang, Yongsheng Ren, Vishnu C. Ramani, Li Nan, Larry J. Suva, Ralph D. Sanderson	2010	56
8	Pediatric medulloblastoma xenografts including molecular subgroup 3 and CD133+ and CD15+ cells are sensitive to killing by oncolytic herpes simplex viruses Neuro-Oncology ·Gregory K. Friedman, Blake P. Moore, Li Nan, Virginia Kelly, Tina Etminan, Catherine P. Langford, Hui Xu, Xiaosi Han, James M. Markert, Elizabeth A. Beierle, G. Yancey Gillespie	2015	54
9	β-catenin nuclear translocation in colorectal cancer cells is suppressed by PDE10A inhibition, cGMP elevation, and activation of PKG Oncotarget ·Kevin Lee, Ashley S. Lindsey, Li Nan, Bernard D. Gary, Joel Andrews, Adam B. Keeton, Gary A. Piazza	2015	45
10	Anti-Tumor Efficacy of a Novel Antisense Anti-MDM2 Mixed-Backbone Oligonucleotide in Human Colon Cancer Models: p53-Dependent and p53-Independent Mechanisms Molecular Medicine ·Hui Wang, Li Nan, Dong Soo Yu, J. Russell Lindsey, Sudhir Agrawal, Ruiwen Zhang	2002	41
11	Heparanase inhibits osteoblastogenesis and shifts bone marrow progenitor cell fate in myeloma bone disease Bone ·Jian Ruan, Timothy N. Trotter, Li Nan, Rongcheng Luo, Amjad Javed, Ralph D. Sanderson, Larry J. Suva, Yang Yang	2013	38
12	A Novel Sulindac Derivative Inhibits Lung Adenocarcinoma Cell Growth through Suppression of Akt/mTOR Signaling and Induction of Autophagy Molecular Cancer Therapeutics ·Evrim Gurpinar, William E. Grizzle, John J. Shacka, Burton J. Mader, Li Nan, Nicholas A. Piazza, Suzanne Russo, Adam B. Keeton, Gary A. Piazza	2013	36
13	Aconitum alkaloids induce cardiotoxicity and apoptosis in embryonic zebrafish by influencing the expression of cardiovascular relative genes Toxicology Letters ·Fei Liu, Xu Han, Li Nan, Kun Liu, Weijun Kang	2019	35
14	γ134.5-deleted HSV-1-expressing human cytomegalovirus IRS1 gene kills human glioblastoma cells as efficiently as wild-type HSV-1 in normoxia or hypoxia Gene Therapy ·Gregory K. Friedman, Li Nan, Marilyn C. Haas, V. Kelly, Blake P. Moore, Catherine P. Langford, Hongxia Xu, Xiaosi Han, Elizabeth A. Beierle, James M. Markert, Kevin A. Cassady, G. Yancey Gillespie	2014	29
15	Safety and efficacy of oncolytic HSV-1 G207 inoculated into the cerebellum of mice Cancer Gene Therapy ·Joshua D. Bernstock, Nunzio Vicario, Rong Li, Li Nan, Stacie K. Totsch, Charles Schlappi, Florian Geßler, Xiaosi Han, Rosalba Parenti, Elizabeth A. Beierle, Richard J. Whitley, Inmaculada Aban, G. Yancey Gillespie, James M. Markert, Gregory K. Friedman	2019	29
16	Novel non-cyclooxygenase inhibitory derivatives of naproxen for colorectal cancer chemoprevention Medicinal Chemistry Research ·Tarek Aboul‐Fadl, Suliman S. Al-Hamad, Kevin Lee, Li Nan, Bernard D. Gary, Adam B. Keeton, Gary A. Piazza, Mohammed K. Abdel‐Hamid	2014	20
17	Artificial Rearing of Mouse Pups: Development of a Mouse Pup in a Cup Model Pediatric Research ·Elizabeth A. Beierle, Mike K. Chen, Joseph E. Hartwich, Meera Iyengar, Wei Dai, Li Nan, Vince Demarco, Josef Neu	2004	19
18	Antisense anti-MDM2 mixed-backbone oligonucleotides enhance therapeutic efficacy of topoisomerase I inhibitor irinotecan in nude mice bearing human cancer xenografts: In vivo activity and mechanisms International Journal of Oncology ·H. Wang, Simeng Wang, Li Nan, Dong Yu, Sudhir Agrawal, R. Zhang	2002	19
19	Feline Panleukopenia Virus With G299E Substitution in the VP2 Protein First Identified From a Captive Giant Panda in China Frontiers in Cellular and Infection Microbiology ·Shushuai Yi, Songrui Liu, Xianyong Meng, Pei Huang, Zengguo Cao, Hongli Jin, Jianzhong Wang, Guixue Hu, Jingchao Lan, Dongsheng Zhang, Yuwei Gao, Hualei Wang, Li Nan, Na Feng, Rong Hou, Songtao Yang, Xianzhu Xia	2022	18
20	Newly Characterized Murine Undifferentiated Sarcoma Models Sensitive to Virotherapy with Oncolytic HSV-1 M002 Molecular Therapy — Oncolytics ·Eric Ring, Rong Li, Blake P. Moore, Li Nan, Virginia Kelly, Xiaosi Han, Elizabeth A. Beierle, James M. Markert, Jianmei W. Leavenworth, G. Yancey Gillespie, Gregory K. Friedman	2017	18

About Li Nan

Li Nan is a scholar working on Molecular Biology, Oncology, Genetics, Epidemiology and Pharmacology, having authored 44 papers that have together received 1.1k indexed citations. Recurring topics across this work include Virus-based gene therapy research (11 papers), Herpesvirus Infections and Treatments (7 papers), Multiple Myeloma Research and Treatments (5 papers), Inflammatory mediators and NSAID effects (5 papers), Cytomegalovirus and herpesvirus research (4 papers), Bone health and treatments (4 papers), Cancer-related Molecular Pathways (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Oncology (375 citations), Genetics (300 citations), Molecular Biology (566 citations), Immunology (166 citations) and Genetics (72 citations). Li Nan has collaborated with scholars based in United States, China and Egypt. Frequent co-authors include Sudhir Agrawal, Gary A. Piazza, Adam B. Keeton, Ruiwen Zhang, Dong Soo Yu, Bernard D. Gary, Elizabeth A. Beierle, Huamiao Wang, James M. Markert and G. Yancey Gillespie. Their work appears in journals such as Neuro-Oncology, Cancer Research, Cancer Prevention Research, Pediatric Research and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact